App-Quantinova.ai

Evaluation of a Novel Scoring Tool to Guide Treatment Decisions in Rheumatoid Arthritis: The Gestaltometer

Henry Averns - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

How does Non-Compliance to Prolia (Denosumab) Affect the Change in Bone Mineral Density (BMD)?

M. Wong-Pack - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Denosumab

The Risk of Cerebrovascular Accidents in Systemic Sclerosis: A Population-Based Cohort Study

Hyon Choi - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Stroke

N/A

The Validation of Administrative Osteoarthritis Diagnosis using a Clinical and Radiological Population-Based Cohort from British Columbia, Canada

Jacek Kopec - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Inflammatory Arthritis

N/A

Do we know how and when to Taper and Stop in Immunosuppressants in Lupus Patients?

Murray Urowitz - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Thrombocytopenia

Prednisone

Disease Activity does not Improve Significantly in One System and Worsen in Another System

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Albuminuria

Prednisone

Venous Thromboembolic Events in Patients with Granulomatosis with Polyangiitis: A Population Based Study

Neda Amiri - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Wegener's granulomatosis

N/A

Procedural Pain with Weekly Injections of Subcutaneous Methotrexate in Children with Rheumatic Disorders.

Julie Lemieux - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Methotrexate

Lower Socioeconomic Status Associates with Increased Symptom Severity and Functional Impairment in Fibromyalgia

Emmanouil Rampakakis - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Fibromyalgia

N/A

Risk of Cardiovascular Events in Patients with Granulomatosis with Polyangiitis: A Population Based Study

Natasha Dehghan - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Wegener's granulomatosis

N/A

Rat Bite Fever Resembling Rheumatoid Arthritis in a 46 Year Old Female

Paul Boland - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Rheumatoid arthritis

Hydroxychloroquine

Comparison of Systemic Sclerosis Subsets Based on Skin and Serology

Marie Hudson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Low Socioeconomic Status at Diagnosis Predicts High Health Resource Utilization and Direct Medical Costs in Systemic Lupus Erythematosus

Carlo Marra - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

RheumExam Atlas: A Web-Based Photographic Atlas to Support Physical Exam Teaching

Lori Albert - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Intra- and Inter-Rater Reliability between a Trainee and Expert in Plain Radiographic Evaluation of Femoroacetabular Impingement

Jolanda Cibere - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Factors Affecting the Discrepancy between Physician and Patient Global Assessment of Disease Activity in Early and Established Rheumatoid Arthritis Patients- Results from the Ontario Best Practices Initiative

Binu Jacob - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled

Arthur Kavanaugh - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Sulfasalazine

Anti-Ro Antibodies and Cancer in Systemic Lupus Erythematosus

Ann Clarke - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Development and Usability Testing of the Arthritis Health Journal: An Online Tool to Promote Self- Monitoring with Rheumatoid Arthritis

Erin Carruthers - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Improving the Ordering of Hand and Wrist Ultrasound to Manage Inflammatory Arthritis

Dana Jerome - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Filters

28841 Abstracts